MSMukhammad A. Sayfullin

Mukhammad A. Sayfullin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mukhammad A. Sayfullin has a total of 235 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serological Profile of COVID-19 in Children with Comorbidities during Omicron Variant Circulation

    by M. S. Rajkovic, S. B. Chuelov, R. F. Sayfullin, Д. Д. Савельева, A. V. Belyakova, A. N. Slatetskaya, A. L. Rossina, M. A. Sayfullin, N. A. Mayanskiy, E. E. Petryaykina, et al.

    Тhe characteristics of the humoral immune response to SARS-CoV-2 in children, particularly those with comorbid conditions, remain incompletely understood. The observed variability in antibody production and the sensitivity of serological assays complicate the objective assessment of seroconversion in the pediatric population.Objective: To determine the qualitative and quantitative profiles of IgM and IgG antibodies against SARS-CoV-2 in children with somatic comorbidities during the acute phase of COVID-19 amid the circulation of the Omicron variant.Materials and Methods: A prospective, single-center, non-randomized cohort study was conducted involving hospitalized children with confirmed COVID-19 and underlying chronic conditions. Serological testing was performed on days 1, 8, and 14 of illness using enzyme-linked immunosorbent assay (ELISA) and immunochemiluminescence assay (ICLA) to measure IgM and IgG levels.Results: A total of 99 children with comorbidities were included in the analysis. The seropositivity rate for IgM remained low at all time points (up to 26.3% on day 14). IgG antibodies were detected in the majority of patients as early as day 1, with ELISA demonstrating higher sensitivity (77.6%) compared to ICLA (60%), peak IgG levels were observed on day 8, followed by a significant decline by day 14 (p < 0.01). Children with respiratory system diseases exhibited statistically higher IgG levels compared to those with hemoblastoses, solid tumors, primary immunodeficiencies, and nervous system disorders.Conclusions: Serological diagnosis of COVID-19 in children with comorbidities requires careful consideration of the testing method, disease timeline, and type of underlying somatic pathology. IgG antibodies serve as a more informative marker than IgM, with ELISA offering superior sensitivity.

  • Open Access

    COVID-19 in children with chronic digestive system pathology

    by M. S. Rajkovic, S. B. Chuelov, S. K. Pylaeva, Д. Д. Савельева, A. A. Chernysheva, A. L. Rossina, M. A. Sayfullin, A. N. Slatetskaya, E. G. Tsimbalova, E. E. Petryaykina, et al.

    COVID-19 in children is characterized by a predominance of mild and asymptomatic forms, along with frequent gastrointestinal symptoms. It is known that comorbid conditions are a risk factor for severe COVID-19 in children; however, the course of SARS-CoV-2 infection in children with chronic digestive system diseases remains under-researched. Objective. To identify the specific characteristics of COVID-19 in children with chronic digestive system diseases, assess risk factors for severe COVID-19, and evaluate the impact of immunosuppressive therapy on COVID-19 outcomes. Materials and Methods. A single-center cohort retrospective and prospective non-randomized study was conducted, including 74 patients with COVID-19 and chronic digestive system diseases and a control group of 30 patients with COVID-19 without comorbidities, all hospitalized in the infectious disease department of the Russian Children’s Clinical Hospital, Moscow, in 2022 and 2023. Results. Сhildren with underlying digestive system diseases were not at a higher risk of severe COVID-19 compared to the control group. Severe, uncontrolled somatic disease and the presence of two or more comorbidities were risk factors for complicated SARS-CoV-2 infection. The duration of detectable SARS-CoV-2 RNA in the study group was nine days. Conclusion. Patients with chronic digestive system diseases, including those receiving immunosuppressive therapy, do not appear to be at higher risk for severe or unfavorable COVID-19 outcomes; however, prolonged SARS-CoV-2 RNA shedding was observed. Risk factors for severe COVID-19 include the presence of two or more comorbidities and severe somatic disease.


  • Open Access

    COVID-19 in children with somatic pathology

    by M. S. Rajkovic, S. B. Chuelov, S. K. Pylaeva, Д. Д. Савельева, А. А. Chernysheva, S. A. Tosoeva, D. D. Namazova, J. N. Ivanova, A. N. Slatetskaya, A. L. Rossina, et al.

    The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of the SARS-CoV-2 infection course in children with comorbidities remain insufficiently studied. The aim of this study was to evaluate the clinical form, severity, and duration of SARS-CoV-2 virus shedding in pediatric patients with somatic diseases, depending on the comorbid pathology. Materials and Methods. A comprehensive single-center retrospective study was conducted, analyzing 314 medical records of patients hospitalized in the infectious diseases department of the Russian Children’s Clinical Hospital in Moscow over 11 months in 2022. The inclusion criterion was the presence of a laboratory-confirmed COVID-19 diagnosis. Results. Children with comorbidities were found to be predisposed to a more severe course of SARS-CoV-2 infection compared to the pediatric population in general. Children with hematological diseases were at the highest risk of adverse outcomes from COVID-19. Patients with oncological and hematological diseases and primary immunodeficiencies shed the SARS-CoV-2 virus significantly longer than patients with other somatic pathologies. The duration of SARS-CoV-2 RNA detection in patients with severe COVID-19 was significantly longer, which also correlated with the severity of the underlying somatic disease. Conclusion. Children with comorbidities are at risk for a more severe and prolonged course of SARS-CoV-2 infection.


  • Open Access

    Results of monitoring probable cases of acute severe hepatitis of unknown etiology in children in Мoscow in 2022

    by М. А. Sayfullin, L. N. Mazankova, A. Yu. Rtischev, E. N. Abramova, N. A. Antypyat, N. N. Zvereva, O. A. Ivanova, M. A. Kolikova, A. A. Rakhalina, K. K. Rumyantseva, et al.

    In the spring 2022, the number of cases of severe acute hepatitis of unknown etiology was unusual increased in Europe. As an immediate response, the World health organization recommended active efforts to identify such cases at the international level. For monitoring of acute hepatitis in Moscow, patients with suspected liver disease were sent to Infectious Diseases Clinical Hospital No. 1. The goal: study of the structure of diseases occurring with liver damage in children hospitalized in 2022. Materials and methods: analysis of medical records of children hospitalized with a diagnosis of hepatitis from May 1 to December 31, 2022. Еpidemiological data (age, gender, parenteral manipulations, contacts with patients, travel abroad), clinical (fever, jaundice, etc.), laboratory parameters were assessed. Results: A total of 164 completed cases of hepatitis in children aged 5 months to 17 years were analyzed. 36 children met the criteria for probable severe acute hepatitis of unknown etiology. Age median was 7 years [2.25;11]. Girls made up more than half (21 (58.3%). Non-infectious genesis was established in 15 (41.6%). The infectious disease was verified in 11 (30.5%), of which adenoviral infection was detected in 2 children. In 9 (25%) children the etiology of hepatitis was not established. Conclusion. Various infectious and non-infectious diseases among hospitalized children lead to a significant increase in liver transaminases. Most acute hepatitis with unspecified etiology proceeded as an acute infectious disease and ended in recovery. The role of adenoviruses in the development of severe hepatitis in children was not confirmed in our study.

  • Open Access

    Algorithm for monitoring patients after tick bite in the context of Lyme-borreliosis

    by R. F. Sayfullin, N. N. Zvereva, A. A. Erovichenkov, A. K. Shakaryan, M. A. Sayfullin, A. A. Samkov, E. V. Kardonova, O. V. Shamsheva

    Timely diagnosis of Lyme-borreliosis (LB) is the key to its successful treatment. Outpatient monitoring of patients after tick bite based on the algorithm is able to optimize the early diagnosis of LB, shorten the start of treatment and improve the disease surveillance.Purpose. Creation of an algorithm for monitoring patients after tick bite for use in outpatient settings by primary care physicians. Material and methods. A retrospective, non-randomized, single-center cohort study was conducted based on the analysis of data from 660 outpatient records of patients consulted by an infectious disease specialist in the Infectious clinical hospital No.1 in Moscow. Patients were divided by age and the presence or absence of a diagnosis of LB. Confirmation of the diagnosis was carried out according to clinical and/or laboratory criteria using methods of enzyme-linked immunoassay and immune blot. Results. The analysis of the results of enzyme immunoassay of antibodies to borrelia in patients with LB was carried out. The optimal sampling time was 7 or more weeks from the moment of tick bite and 4 or more weeks from the moment of onset of symptoms. The specificity of immunological diagnostics in patients with excluded LB was evaluated. The proportion of doubtful and false positive results in such patients was high — 28.1%. False positive results were more common in adults (37.6%) compared with children (9.8%), which is associated with more frequent false positive results of IgM determination (34.1% in adults, 4.9% in children). Based on the data of our study, an algorithm for monitoring patients after tick bite has been developed, focused on use in outpatient settings by primary care physicians.


  • Open Access

    Using of protective masks after the cancelling of the COVID-19 pandemic restrictions: Prospective cohort research

    by E. Yu. Pylaeva, D. V. Orlov, N. A. Marudenkov, E. A. Koltsova, M. G. Tataryan, A. A. Litsev, N. N. Zvereva, I. M. Spivak, O. V. Shamsheva, M. A. Sayfullin

    The long-term using of protective masks, linked with the COVID-19 pandemic, could has a significant impact on people from negativism to addiction to use them. Aim: to assess the frequency of mask use after the canceling of restrictions depending on gender and behavioral characteristics, to assess the possible impact of not wearing masks on the incidence of COVID-19. Materials and Methods: We conducted a prospective longitudinal cohort study on the Moscow Metro from 03/15/22 to 04/11/2022. Three cohorts of passengers were identified: K1 — using masks, K2 — wearing masks with defection from rules and K3 — not using masks. The shares of cohorts were determined depending on gender, travel area, time of day, occupation (use of paper information carriers, electronic devices). The proportions, their confidence intervals were determined; the comparison of the significance of differences was carried out using the Pearson chi-square method. Results: we made 28672 observations covering 225 out of 348 metro stations (67.5%). Within 5 weeks (11—15 weeks of 2022 year), the proportion of passengers not using masks (K3) increased from 74% to 94.6%. Starting from the 2nd day, significant differences between men and women were identified. The largest share of K3 passengers was among those using electronic devices. Among those using paper, the trend towards the elimination of masks was the least pronounced. The decrease in passengers using masks in Moscow did not lead to an increase in the incidence of COVID-19. Conclusion: in the absence of legal restrictions, the decision to use masks is influenced by the gender and behavioral characteristics of passengers.

  • Open Access

    Awareness of Russian tourists traveling to tropical and equatorial countries about the prevention of infectious diseases during travel

    by N. N. Zverevа, E. Y. Pylaeva, A. A. Erovichenkov, M. A. Sayfullin, T. N. Elagina, V. A. Tovstik, R. F. Sayfullin, N. A. Antipyat, O. V. Shamsheva

    Информированность российских туристов, выезжающих в тропические страны, о профилактике инфекционных болезней во время путешествия


  • Open Access

    Detection of Dengue virus RNA in various biological fluids in acute and convalescent phases

    by N.N. Zvereva, L.S. Karan, R.F. Sayfullin, Ya.E. Grigoreva, E.S. Morozkin, N.YU. Pshenichcnaya, S.V. Smetanina, 125367 City Infectious Clinical Hospital No. 1, M.A. Sayfullin

    Выявление РНК вируса денге в различных биологических жидкостях

  • Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report

    by I.Kh. Belyaletdinova, M.A. Sayfullin, G.D. Guseva, Moscow City Infectious Clinical Hospital No. 1, N.E. Perekopskaya

    Мультисистемный воспалительный синдром, ассоциированный с коронавирусной инфекцией COVID-19, у взрослого пациента: клиническое наблюдение

  • Open Access

    Molecular epidemiological analysis of SARS-CoV-2 genovariants in Moscow and Moscow region

    by E N Ozhmegova, T E Savochkina, A G Prilipov, E Tikhomirov, V F Larichev, M A Sayfullin, T V Grebennikova

    Introduction. SARS-CoV-2, a severe acute respiratory illness virus that emerged in China in late 2019, continues to spread rapidly around the world, accumulating mutations and thus causing serious concern. Five virus variants of concern are currently known: Alpha (lineage B.1.1.7), Beta (lineage B.1.351), Gamma (lineage P.1), Delta (lineage B.1.617.2), and Omicron (lineage B.1.1.529). In this study, we conducted a molecular epidemiological analysis of the most prevalent genovariants in Moscow and the region. The aim of the study is to estimate the distribution of various variants of SARS-CoV-2 in Moscow city and the Moscow Region. Materials and methods. 227 SARS-CoV-2 sequences were used for analysis. Isolation of the SARS-CoV-2 virus was performed on Vero E6 cell culture. Sequencing was performed by the Sanger method. Bioinformatic analysis was carried out using software packages: MAFFT, IQ-TREE v1.6.12, jModelTest 2.1.7, Nextstrain, Auspice v2.34. Results. As a result of phylogenetic analysis, we have identified the main variants of the virus circulating in Russia that have been of concern throughout the existence of the pandemic, namely: variant B.1.1.7, which accounted for 30% (9/30), AY.122, which accounted for 16.7% (5/30), BA.1.1 with 20% (6/30) and B.1.1 with 33.3% (10/30). When examining Moscow samples for the presence of mutations in SARS-CoV-2 structural proteins of different genovariants, a significant percentage of the most common substitutions was recorded: S protein D614G (86.7%), P681H/R (63.3%), E protein T9I (20.0%); M protein I82T (30.0%), D3G (20.0%), Q19E (20.0%) and finally N protein R203K/M (90.0%), G204R/P (73.3 %). Conclusion. The study of the frequency and impact of mutations, as well as the analysis of the predominant variants of the virus are important for the development and improvement of vaccines for the prevention of COVID-19. Therefore, ongoing molecular epidemiological studies are needed, as these data provide important information about changes in the genome of circulating SARS-CoV-2 variants.